| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.657 | 0.004 | 0.657 | Calcium channel L-type activator | 0.64 0.004 DBMET01455 | ||
| 0.637 | 0.014 | 0.637 | Cholesterol antagonist | 0.618 0.016 DBMET01455 | ||
| 0.635 | 0.014 | 0.635 | Aldehyde oxidase inhibitor | 0.57 0.023 DBMET01455 | ||
| 0.557 | 0.003 | 0.559 | Calcium channel activator | 0.559 0.003 DBMET01455 | DBMET01455 | |
| 0.554 | 0.006 | 0.554 | Peroxidase inhibitor | 0.47 0.012 DBMET01455 | ||
| 0.548 | 0.005 | 0.548 | Anesthetic general | 0.533 0.006 DBMET01455 | ||
| 0.551 | 0.014 | 0.551 | GABA C receptor rho-3 antagonist | 0.452 0.041 DBMET01455 | ||
| 0.559 | 0.036 | 0.582 | Transcription factor NF kappa B inhibitor | 0.582 0.033 DBMET01455 | DBMET01455 | |
| 0.543 | 0.033 | 0.56 | 15-Lipoxygenase inhibitor | 0.56 0.03 DBMET01455 | DBMET01455 | |
| 0.532 | 0.023 | 0.532 | Vasodilator, peripheral | 0.528 0.023 DBMET01455 | ||
| 0.546 | 0.046 | 0.546 | Caspase 9 stimulant | 0.487 0.065 DBMET01455 | ||
| 0.521 | 0.026 | 0.521 | 5 Hydroxytryptamine release inhibitor | 0.497 0.033 DBMET01455 | ||
| 0.466 | 0.006 | 0.466 | 5 Hydroxytryptamine uptake stimulant | 0.406 0.013 DBMET01455 | ||
| 0.476 | 0.019 | 0.476 | Free radical scavenger | 0.462 0.02 DBMET01455 | ||
| 0.469 | 0.016 | 0.469 | Superoxide dismutase inhibitor | 0.364 0.033 DBMET01455 | ||
| 0.48 | 0.036 | 0.48 | Histamine release inhibitor | 0.44 0.055 DBMET01455 | ||
| 0.513 | 0.082 | 0.513 | Antiinflammatory | 0.484 0.094 DBMET01455 | ||
| 0.453 | 0.026 | 0.453 | Antioxidant | 0.447 0.027 DBMET01455 | ||
| 0.453 | 0.027 | 0.512 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.512 0.018 DBMET01455 | DBMET01455 | |
| 0.428 | 0.004 | 0.428 | Histidine decarboxylase inhibitor | 0.347 0.005 DBMET01455 | ||
| 0.447 | 0.024 | 0.447 | Vasodilator, coronary | 0.429 0.027 DBMET01455 | ||
| 0.446 | 0.027 | 0.462 | Lipoxygenase inhibitor | 0.462 0.024 DBMET01455 | DBMET01455 | |
| 0.446 | 0.031 | 0.446 | Caspase 3 stimulant | 0.403 0.044 DBMET01455 | ||
| 0.412 | 0.005 | 0.412 | Interleukin 4 antagonist | 0.347 0.006 DBMET01455 | ||
| 0.418 | 0.012 | 0.418 | Dual specificity phosphatase 3 inhibitor | 0.401 0.014 DBMET01455 | ||
| 0.424 | 0.019 | 0.424 | Vasodilator | 0.38 0.027 DBMET01455 | ||
| 0.408 | 0.007 | 0.408 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.394 0.008 DBMET01455 | ||
| 0.432 | 0.032 | 0.466 | 12-Lipoxygenase inhibitor | 0.466 0.026 DBMET01455 | DBMET01455 | |
| 0.416 | 0.016 | 0.446 | RNA-directed DNA polymerase inhibitor | 0.446 0.014 DBMET01455 | DBMET01455 | |
| 0.41 | 0.014 | 0.41 | Sodium/bile acid cotransporter inhibitor | 0.402 0.016 DBMET01455 | ||
| 0.408 | 0.017 | 0.414 | Transcription factor STAT3 inhibitor | 0.414 0.016 DBMET01455 | DBMET01455 | |
| 0.474 | 0.083 | 0.474 | Apoptosis agonist | 0.463 0.086 DBMET01455 | ||
| 0.391 | 0.004 | 0.391 | Carbonic anhydrase XV inhibitor | 0.389 0.004 DBMET01455 | ||
| 0.387 | 0.004 | 0.387 | Porphobilinogen synthase inhibitor | 0.318 0.005 DBMET01455 | ||
| 0.39 | 0.009 | 0.39 | Protein-tyrosine phosphatase inhibitor | 0.336 0.014 DBMET01455 | ||
| 0.393 | 0.014 | 0.393 | Non-steroidal antiinflammatory agent | 0.373 0.017 DBMET01455 | ||
| 0.393 | 0.015 | 0.393 | Dual specificity phosphatase inhibitor | 0.38 0.017 DBMET01455 | ||
| 0.397 | 0.019 | 0.398 | Transcription factor STAT inhibitor | 0.398 0.019 DBMET01455 | DBMET01455 | |
| 0.387 | 0.011 | 0.421 | Interferon gamma antagonist | 0.421 0.01 DBMET01455 | DBMET01455 | |
| 0.379 | 0.005 | 0.379 | Cystathionine beta-synthase inhibitor | 0.34 0.007 DBMET01455 | ||
| 0.402 | 0.029 | 0.402 | Hypoxia-inducible factor 1 alpha inhibitor | 0.381 0.035 DBMET01455 | ||
| 0.46 | 0.092 | 0.529 | Alpha-glucosidase inhibitor | 0.529 0.072 DBMET01455 | DBMET01455 | |
| 0.378 | 0.011 | 0.378 | Tyrosine 3 hydroxylase inhibitor | 0.323 0.024 DBMET01455 | ||
| 0.377 | 0.01 | 0.377 | Alpha-N-acetylglucosaminidase inhibitor | 0.306 0.015 DBMET01455 | ||
| 0.386 | 0.027 | 0.386 | Amyloid beta aggregation inhibitor | 0.327 0.04 DBMET01455 | ||
| 0.36 | 0.004 | 0.36 | Macrophage migration inhibitory factor inhibitor | 0.329 0.004 DBMET01455 | ||
| 0.359 | 0.004 | 0.359 | GABA C receptor rho-2 antagonist | 0.267 0.009 DBMET01455 | ||
| 0.413 | 0.063 | 0.459 | Prostaglandin dehydrogenase inhibitor | 0.459 0.051 DBMET01455 | DBMET01455 | |
| 0.348 | 0.004 | 0.348 | Alcohol oxidase inhibitor | 0.154 0.01 DBMET01455 | ||
| 0.345 | 0.004 | 0.345 | Catenin beta inhibitor | 0.31 0.005 DBMET01455 | ||
| 0.344 | 0.006 | 0.344 | Succinate dehydrogenase inhibitor | 0.293 0.012 DBMET01455 | ||
| 0.339 | 0.004 | 0.339 | Keratolytic | 0.292 0.004 DBMET01455 | ||
| 0.357 | 0.024 | 0.357 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 DBMET01455 | ||
| 0.344 | 0.017 | 0.37 | Melanin inhibitor | 0.37 0.014 DBMET01455 | DBMET01455 | |
| 0.371 | 0.047 | 0.371 | Apoptosis antagonist | 0.35 0.056 DBMET01455 | ||
| 0.323 | 0.004 | 0.452 | TRPA1 agonist | 0.452 0.004 DBMET01455 | DBMET01455 | |
| 0.348 | 0.03 | 0.348 | Interleukin agonist | 0.323 0.038 DBMET01455 | ||
| 0.333 | 0.017 | 0.333 | DNA methyltransferase I inhibitor | 0.315 0.021 DBMET01455 | ||
| 0.317 | 0.002 | 0.317 | DOPA decarboxylase inhibitor | 0.278 0.003 DBMET01455 | ||
| 0.327 | 0.015 | 0.327 | Monophenol monooxygenase inhibitor | 0.32 0.016 DBMET01455 | ||
| 0.328 | 0.016 | 0.328 | Lipocortins synthesis antagonist | 0.311 0.019 DBMET01455 | ||
| 0.318 | 0.01 | 0.318 | NADPH oxidase inhibitor | 0.314 0.011 DBMET01455 | ||
| 0.35 | 0.048 | 0.371 | Aryl hydrocarbon receptor agonist | 0.371 0.043 DBMET01455 | DBMET01455 | |
| 0.385 | 0.084 | 0.385 | Antibacterial | 0.385 0.084 DBMET01455 | ||
| 0.338 | 0.038 | 0.355 | Pyruvate kinase inhibitor | 0.355 0.032 DBMET01455 | DBMET01455 | |
| 0.309 | 0.012 | 0.337 | Anesthetic local | 0.337 0.01 DBMET01455 | DBMET01455 | |
| 0.318 | 0.023 | 0.318 | DNA methylase inhibitor | 0.286 0.032 DBMET01455 | ||
| 0.355 | 0.063 | 0.355 | Antithrombotic | 0.326 0.074 DBMET01455 | ||
| 0.327 | 0.036 | 0.327 | DNA synthesis inhibitor | 0.314 0.039 DBMET01455 | ||
| 0.308 | 0.017 | 0.345 | Amylase inhibitor | 0.345 0.013 DBMET01455 | DBMET01455 | |
| 0.295 | 0.005 | 0.31 | Mannose-6-phosphate isomerase inhibitor | 0.31 0.005 DBMET01455 | DBMET01455 | |
| 0.331 | 0.042 | 0.331 | Insulysin inhibitor | 0.32 0.047 DBMET01455 | ||
| 0.305 | 0.016 | 0.357 | Protein kinase stimulant | 0.357 0.011 DBMET01455 | DBMET01455 | |
| 0.288 | 0.004 | 0.288 | Heat shock protein 70 antagonist | 0.269 0.004 DBMET01455 | ||
| 0.306 | 0.022 | 0.312 | Mcl-1 antagonist | 0.312 0.021 DBMET01455 | DBMET01455 | |
| 0.34 | 0.059 | 0.34 | 5 Hydroxytryptamine release stimulant | 0.191 0.129 DBMET01455 | ||
| 0.282 | 0.004 | 0.282 | CD45 antagonist | 0.111 0.008 DBMET01455 | ||
| 0.289 | 0.012 | 0.289 | Protein-tyrosine phosphatase 1B inhibitor | 0.244 0.018 DBMET01455 | ||
| 0.397 | 0.121 | 0.47 | DNA polymerase beta inhibitor | 0.47 0.095 DBMET01455 | DBMET01455 | |
| 0.312 | 0.037 | 0.312 | Sigma receptor agonist | 0.209 0.059 DBMET01455 | ||
| 0.285 | 0.011 | 0.285 | UDP-glucose 4-epimerase inhibitor | 0.213 0.016 DBMET01455 | ||
| 0.293 | 0.019 | 0.293 | Amyloid beta precursor protein antagonist | 0.277 0.024 DBMET01455 | ||
| 0.331 | 0.059 | 0.331 | Spasmolytic | 0.315 0.064 DBMET01455 | ||
| 0.279 | 0.009 | 0.279 | Xanthine oxidase inhibitor | 0.265 0.01 DBMET01455 | ||
| 0.389 | 0.12 | 0.466 | DNA directed DNA polymerase inhibitor | 0.466 0.092 DBMET01455 | DBMET01455 | |
| 0.279 | 0.013 | 0.279 | Chelator | 0.216 0.022 DBMET01455 | ||
| 0.271 | 0.005 | 0.272 | Photosensitizer | 0.272 0.005 DBMET01455 | DBMET01455 | |
| 0.331 | 0.068 | 0.35 | Streptokinase A inhibitor | 0.35 0.062 DBMET01455 | DBMET01455 | |
| 0.267 | 0.006 | 0.267 | HIV-1 integrase (3'-Processing) inhibitor | 0.255 0.006 DBMET01455 | ||
| 0.296 | 0.035 | 0.312 | Gastrin inhibitor | 0.312 0.025 DBMET01455 | DBMET01455 | |
| 0.271 | 0.01 | 0.271 | Expectorant | 0.248 0.013 DBMET01455 | ||
| 0.339 | 0.081 | 0.372 | Thioredoxin glutathione reductase inhibitor | 0.372 0.067 DBMET01455 | DBMET01455 | |
| 0.278 | 0.02 | 0.278 | Phospholipase C inhibitor | 0.252 0.024 DBMET01455 | ||
| 0.267 | 0.012 | 0.267 | GABA C receptor agonist | 0.178 0.025 DBMET01455 | ||
| 0.373 | 0.126 | 0.373 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.365 0.134 DBMET01455 | ||
| 0.297 | 0.05 | 0.297 | Angiogenesis stimulant | 0.283 0.056 DBMET01455 | ||
| 0.25 | 0.004 | 0.25 | Glutamate release inhibitor | 0.173 0.006 DBMET01455 | ||
| 0.27 | 0.025 | 0.27 | Insulin sensitizer | 0.261 0.029 DBMET01455 | ||
| 0.253 | 0.009 | 0.253 | Cyclooxygenase 3 inhibitor | 0.222 0.013 DBMET01455 | ||
| 0.266 | 0.024 | 0.291 | Lipid peroxidase inhibitor | 0.291 0.02 DBMET01455 | DBMET01455 | |
| 0.283 | 0.042 | 0.283 | 5 Hydroxytryptamine 1E antagonist | 0.282 0.043 DBMET01455 | ||
| 0.248 | 0.006 | 0.248 | HIV-1 integrase (Strand Transfer) inhibitor | 0.231 0.007 DBMET01455 | ||
| 0.251 | 0.009 | 0.251 | Toll-Like receptor 2 antagonist | 0.247 0.009 DBMET01455 | ||
| 0.36 | 0.126 | 0.414 | Transcription factor inhibitor | 0.414 0.104 DBMET01455 | DBMET01455 | |
| 0.254 | 0.022 | 0.254 | Phospholipase A2 inhibitor | 0.23 0.029 DBMET01455 | ||
| 0.276 | 0.045 | 0.276 | Nitric oxide antagonist | 0.272 0.046 DBMET01455 | ||
| 0.236 | 0.006 | 0.236 | HIV-1 integrase (Overall Integration) inhibitor | 0.2 0.012 DBMET01455 | ||
| 0.257 | 0.028 | 0.257 | Nitric-oxide synthase stimulant | 0.254 0.03 DBMET01455 | ||
| 0.237 | 0.008 | 0.248 | CF transmembrane conductance regulator agonist | 0.248 0.006 DBMET01455 | DBMET01455 | |
| 0.234 | 0.005 | 0.234 | GABA C receptor rho-1 antagonist | 0.168 0.015 DBMET01455 | ||
| 0.235 | 0.008 | 0.235 | GABA C receptor antagonist | 0.175 0.019 DBMET01455 | ||
| 0.245 | 0.018 | 0.245 | Hexokinase inhibitor | 0.233 0.021 DBMET01455 | ||
| 0.283 | 0.058 | 0.283 | Antiamyloidogenic | 0.266 0.064 DBMET01455 | ||
| 0.234 | 0.01 | 0.234 | Arachidonic acid antagonist | 0.228 0.013 DBMET01455 | ||
| 0.24 | 0.016 | 0.271 | ATPase inhibitor | 0.271 0.009 DBMET01455 | DBMET01455 | |
| 0.246 | 0.022 | 0.255 | M18 aspartyl aminopeptidase inhibitor | 0.255 0.02 DBMET01455 | DBMET01455 | |
| 0.242 | 0.018 | 0.242 | DNA polymerase I inhibitor | 0.227 0.021 DBMET01455 | ||
| 0.258 | 0.034 | 0.286 | Neurotrophic factor enhancer | 0.286 0.022 DBMET01455 | DBMET01455 | |
| 0.25 | 0.026 | 0.26 | Heat shock protein 90 alpha antagonist | 0.26 0.023 DBMET01455 | DBMET01455 | |
| 0.266 | 0.044 | 0.27 | Platelet adhesion inhibitor | 0.27 0.043 DBMET01455 | DBMET01455 | |
| 0.23 | 0.008 | 0.23 | Mucolytic | 0.207 0.012 DBMET01455 | ||
| 0.232 | 0.011 | 0.232 | Adenylate kinase inhibitor | 0.184 0.018 DBMET01455 | ||
| 0.236 | 0.023 | 0.266 | Alkaline phosphatase inhibitor | 0.266 0.017 DBMET01455 | DBMET01455 | |
| 0.233 | 0.02 | 0.241 | Cholesterol synthesis inhibitor | 0.241 0.019 DBMET01455 | DBMET01455 | |
| 0.225 | 0.012 | 0.225 | Carbonic anhydrase III inhibitor | 0.198 0.017 DBMET01455 | ||
| 0.223 | 0.011 | 0.223 | Carbonic anhydrase XIII inhibitor | 0.213 0.012 DBMET01455 | ||
| 0.23 | 0.019 | 0.23 | 5-Lipoxygenase inhibitor | 0.22 0.021 DBMET01455 | ||
| 0.221 | 0.01 | 0.221 | Uric acid excretion stimulant | 0.183 0.015 DBMET01455 | ||
| 0.208 | 0.004 | 0.208 | GABA aminotransferase inhibitor | 0.183 0.005 DBMET01455 | ||
| 0.246 | 0.044 | 0.246 | Hepatoprotectant | 0.233 0.049 DBMET01455 | ||
| 0.224 | 0.023 | 0.224 | Aldehyde dehydrogenase inhibitor | 0.204 0.027 DBMET01455 | ||
| 0.226 | 0.028 | 0.236 | Heat shock protein 90 antagonist | 0.236 0.025 DBMET01455 | DBMET01455 | |
| 0.294 | 0.096 | 0.382 | Thyroid hormone antagonist | 0.382 0.062 DBMET01455 | DBMET01455 | |
| 0.2 | 0.003 | 0.2 | Granulocyte macrophage colony stimulating factor agonist | 0.15 0.005 DBMET01455 | ||
| 0.28 | 0.085 | 0.28 | Immunostimulant | 0.255 0.094 DBMET01455 | ||
| 0.203 | 0.008 | 0.203 | Electrolyte absorption antagonist | 0.16 0.016 DBMET01455 | ||
| 0.197 | 0.004 | 0.197 | Carbonic anhydrase XIV inhibitor | 0.153 0.005 DBMET01455 | ||
| 0.203 | 0.01 | 0.203 | Creatine kinase inhibitor | 0.161 0.02 DBMET01455 | ||
| 0.199 | 0.009 | 0.199 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.192 0.01 DBMET01455 | ||
| 0.201 | 0.013 | 0.213 | Beta glucuronidase inhibitor | 0.213 0.011 DBMET01455 | DBMET01455 | |
| 0.227 | 0.039 | 0.227 | Tumour necrosis factor antagonist | 0.223 0.041 DBMET01455 | ||
| 0.194 | 0.007 | 0.194 | Glutamate decarboxylase inhibitor | 0.154 0.012 DBMET01455 | ||
| 0.194 | 0.012 | 0.194 | Phosphofructokinase-1 inhibitor | 0.153 0.017 DBMET01455 | ||
| 0.218 | 0.039 | 0.23 | Cytidine deaminase inhibitor | 0.23 0.035 DBMET01455 | DBMET01455 | |
| 0.199 | 0.02 | 0.212 | Microtubule formation inhibitor | 0.212 0.017 DBMET01455 | DBMET01455 | |
| 0.278 | 0.1 | 0.362 | Thyroid hormone beta antagonist | 0.362 0.064 DBMET01455 | DBMET01455 | |
| 0.192 | 0.014 | 0.192 | Calcium antagonist | 0.167 0.018 DBMET01455 | ||
| 0.182 | 0.009 | 0.182 | Toll-Like receptor 4 antagonist | 0.163 0.015 DBMET01455 | ||
| 0.19 | 0.017 | 0.19 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.025 DBMET01455 | ||
| 0.249 | 0.077 | 0.252 | Hypoglycemic | 0.252 0.076 DBMET01455 | DBMET01455 | |
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 DBMET01455 | ||
| 0.175 | 0.005 | 0.175 | Xanthine dehydrogenase inhibitor | 0.147 0.007 DBMET01455 | ||
| 0.182 | 0.013 | 0.182 | Triose-phosphate isomerase inhibitor | 0.159 0.018 DBMET01455 | ||
| 0.172 | 0.003 | 0.172 | Adenine nucleotide translocase inhibitor | 0.172 0.003 DBMET01455 | ||
| 0.181 | 0.014 | 0.181 | Caspase 3 inhibitor | 0.158 0.023 DBMET01455 | ||
| 0.185 | 0.018 | 0.185 | Antineoplastic alkaloid | 0.148 0.028 DBMET01455 | ||
| 0.18 | 0.016 | 0.18 | Breast cancer-resistant protein inhibitor | 0.152 0.023 DBMET01455 | ||
| 0.178 | 0.016 | 0.178 | Carbonic anhydrase VI inhibitor | 0.168 0.017 DBMET01455 | ||
| 0.185 | 0.022 | 0.186 | Adenylate cyclase stimulant | 0.186 0.022 DBMET01455 | DBMET01455 | |
| 0.197 | 0.038 | 0.197 | Tubulin antagonist | 0.193 0.039 DBMET01455 | ||
| 0.165 | 0.008 | 0.165 | Ornithine decarboxylase inhibitor | 0.161 0.009 DBMET01455 | ||
| 0.184 | 0.027 | 0.184 | Neuropeptide Y1 antagonist | 0.179 0.031 DBMET01455 | ||
| 0.184 | 0.027 | 0.23 | Farnesoid X receptor antagonist | 0.23 0.015 DBMET01455 | DBMET01455 | |
| 0.162 | 0.006 | 0.162 | Purinergic P2X1 antagonist | 0.142 0.008 DBMET01455 | ||
| 0.192 | 0.036 | 0.204 | M17 leucyl aminopeptidase inhibitor | 0.204 0.032 DBMET01455 | DBMET01455 | |
| 0.169 | 0.014 | 0.169 | NADH dehydrogenase inhibitor | 0.143 0.019 DBMET01455 | ||
| 0.192 | 0.038 | 0.192 | Cyclooxygenase 1 inhibitor | 0.191 0.038 DBMET01455 | ||
| 0.183 | 0.029 | 0.183 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.171 0.042 DBMET01455 | ||
| 0.19 | 0.041 | 0.19 | Neurotensin receptor agonist | 0.175 0.056 DBMET01455 | ||
| 0.175 | 0.028 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | 0.176 0.028 DBMET01455 | DBMET01455 | |
| 0.151 | 0.007 | 0.165 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.165 0.005 DBMET01455 | DBMET01455 | |
| 0.149 | 0.005 | 0.149 | D-Ala-D-Ala ligase inhibitor | 0.117 0.015 DBMET01455 | ||
| 0.187 | 0.046 | 0.194 | NOS3 expression enhancer | 0.194 0.043 DBMET01455 | DBMET01455 | |
| 0.145 | 0.004 | 0.145 | Estrogen-related receptor beta agonist | 0.141 0.005 DBMET01455 | ||
| 0.163 | 0.023 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.178 0.015 DBMET01455 | DBMET01455 | |
| 0.272 | 0.133 | 0.286 | Immunosuppressant | 0.286 0.124 DBMET01455 | DBMET01455 | |
| 0.162 | 0.024 | 0.162 | Potassium channel (Ca-activated) activator | 0.113 0.045 DBMET01455 | ||
| 0.164 | 0.027 | 0.177 | Vanilloid 1 agonist | 0.177 0.02 DBMET01455 | DBMET01455 | |
| 0.142 | 0.006 | 0.142 | Maillard reaction inhibitor | 0.131 0.008 DBMET01455 | ||
| 0.151 | 0.017 | 0.151 | Interleukin 1 beta converting enzyme inhibitor | 0.13 0.028 DBMET01455 | ||
| 0.166 | 0.032 | 0.187 | Ferrochelatase inhibitor | 0.187 0.026 DBMET01455 | DBMET01455 | |
| 0.152 | 0.017 | 0.153 | Anabolic | 0.153 0.016 DBMET01455 | DBMET01455 | |
| 0.228 | 0.094 | 0.228 | DNA damaging | 0.188 0.126 DBMET01455 | ||
| 0.18 | 0.048 | 0.18 | MAO inhibitor | 0.175 0.049 DBMET01455 | ||
| 0.25 | 0.118 | 0.251 | Interleukin 2 agonist | 0.251 0.117 DBMET01455 | DBMET01455 | |
| 0.21 | 0.079 | 0.21 | Interleukin antagonist | 0.161 0.11 DBMET01455 | ||
| 0.153 | 0.022 | 0.153 | Estrogen antagonist | 0.14 0.028 DBMET01455 | ||
| 0.156 | 0.028 | 0.156 | Protein kinase C gamma inhibitor | 0.123 0.05 DBMET01455 | ||
| 0.164 | 0.036 | 0.17 | Antibacterial (Helicobacter pylori) | 0.17 0.033 DBMET01455 | DBMET01455 | |
| 0.138 | 0.01 | 0.138 | HIV-1 integrase inhibitor | 0.124 0.014 DBMET01455 | ||
| 0.14 | 0.013 | 0.14 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 DBMET01455 | ||
| 0.198 | 0.072 | 0.21 | Histone acetyltransferase inhibitor | 0.21 0.055 DBMET01455 | DBMET01455 | |
| 0.151 | 0.026 | 0.151 | Catalase inhibitor | 0.098 0.039 DBMET01455 | ||
| 0.129 | 0.005 | 0.129 | GABA B receptor agonist | 0.116 0.009 DBMET01455 | ||
| 0.178 | 0.055 | 0.178 | Diuretic | 0.175 0.057 DBMET01455 | ||
| 0.151 | 0.028 | 0.151 | Mediator release inhibitor | 0.146 0.03 DBMET01455 | ||
| 0.14 | 0.018 | 0.14 | Estrogen receptor beta antagonist | 0.13 0.023 DBMET01455 | ||
| 0.16 | 0.039 | 0.16 | Adenylate cyclase inhibitor | 0.143 0.05 DBMET01455 | ||
| 0.155 | 0.035 | 0.165 | Sphingosine 1-phosphate receptor 2 antagonist | 0.165 0.025 DBMET01455 | DBMET01455 | |
| 0.124 | 0.005 | 0.124 | Glutamate (mGluR6) antagonist | 0.116 0.006 DBMET01455 | ||
| 0.128 | 0.01 | 0.128 | Elastase 1 inhibitor | 0.107 0.017 DBMET01455 | ||
| 0.157 | 0.039 | 0.157 | MAO A inhibitor | 0.146 0.042 DBMET01455 | ||
| 0.181 | 0.064 | 0.181 | 3C-like protease (Human coronavirus) inhibitor | 0.163 0.082 DBMET01455 | ||
| 0.214 | 0.097 | 0.214 | Neuropeptide Y2 antagonist | 0.193 0.133 DBMET01455 | ||
| 0.121 | 0.005 | 0.121 | Aconitate hydratase inhibitor | 0.076 0.015 DBMET01455 | ||
| 0.13 | 0.018 | 0.13 | Glutathione S-transferase inhibitor | 0.122 0.022 DBMET01455 | ||
| 0.125 | 0.013 | 0.125 | Caspase 7 inhibitor | 0.104 0.024 DBMET01455 | ||
| 0.122 | 0.009 | 0.122 | Neuraminidase inhibitor | 0.103 0.014 DBMET01455 | ||
| 0.173 | 0.061 | 0.173 | Interleukin 6 antagonist | 0.172 0.062 DBMET01455 | ||
| 0.207 | 0.096 | 0.207 | Platelet antagonist | 0.159 0.135 DBMET01455 | ||
| 0.146 | 0.035 | 0.146 | DNA repair enzyme inhibitor | 0.131 0.053 DBMET01455 | ||
| 0.184 | 0.076 | 0.184 | P-glycoprotein inhibitor | 0.183 0.077 DBMET01455 | ||
| 0.12 | 0.013 | 0.121 | Glycine receptor agonist | 0.121 0.012 DBMET01455 | DBMET01455 | |
| 0.161 | 0.054 | 0.161 | Cytokine production inhibitor | 0.146 0.065 DBMET01455 | ||
| 0.129 | 0.022 | 0.129 | Adrenaline agonist | 0.094 0.042 DBMET01455 | ||
| 0.115 | 0.008 | 0.115 | Carbonic anhydrase VII inhibitor | 0.103 0.009 DBMET01455 | ||
| 0.145 | 0.039 | 0.145 | MAO B inhibitor | 0.145 0.039 DBMET01455 | ||
| 0.112 | 0.006 | 0.112 | Potassium channel intermediate-conductance Ca-activated blocker | 0.099 0.009 DBMET01455 | ||
| 0.123 | 0.018 | 0.133 | Bile acid receptor antagonist | 0.133 0.012 DBMET01455 | DBMET01455 | |
| 0.132 | 0.027 | 0.132 | Alcohol dehydrogenase inhibitor | 0.118 0.037 DBMET01455 | ||
| 0.144 | 0.04 | 0.144 | Papain-like protease (SARS coronavirus) inhibitor | 0.136 0.051 DBMET01455 | ||
| 0.12 | 0.016 | 0.12 | Potassium channel large-conductance Ca-activated activator | 0.074 0.04 DBMET01455 | ||
| 0.139 | 0.035 | 0.139 | AMP-activated protein kinase stimulant | 0.121 0.048 DBMET01455 | ||
| 0.133 | 0.03 | 0.133 | Acetylcholine release stimulant | 0.116 0.054 DBMET01455 | ||
| 0.135 | 0.032 | 0.144 | Urease inhibitor | 0.144 0.027 DBMET01455 | DBMET01455 | |
| 0.107 | 0.005 | 0.115 | Urate transporter 1 inhibitor | 0.115 0.005 DBMET01455 | DBMET01455 | |
| 0.106 | 0.007 | 0.106 | Potassium channel Kv1.3 blocker | 0.085 0.011 DBMET01455 | ||
| 0.115 | 0.019 | 0.115 | Beta tubulin antagonist | 0.111 0.019 DBMET01455 | ||
| 0.147 | 0.051 | 0.147 | Topoisomerase II inhibitor | 0.115 0.071 DBMET01455 | ||
| 0.145 | 0.049 | 0.145 | Alkylator | 0.13 0.059 DBMET01455 | ||
| 0.288 | 0.194 | 0.288 | MAP kinase 1 inhibitor | 0.276 0.206 DBMET01455 | ||
| 0.113 | 0.02 | 0.113 | Leukotriene synthesis inhibitor | 0.095 0.029 DBMET01455 | ||
| 0.154 | 0.062 | 0.154 | Cell wall synthesis inhibitor | 0.132 0.083 DBMET01455 | ||
| 0.182 | 0.091 | 0.182 | Psychostimulant | 0.179 0.094 DBMET01455 | ||
| 0.101 | 0.01 | 0.101 | Glutamate (mGluR7) antagonist | 0.088 0.019 DBMET01455 | ||
| 0.114 | 0.024 | 0.114 | Glutamate dehydrogenase inhibitor | 0.098 0.031 DBMET01455 | ||
| 0.116 | 0.027 | 0.116 | Interleukin 5 antagonist | 0.09 0.055 DBMET01455 | ||
| 0.104 | 0.015 | 0.104 | Beta adrenoreceptor antagonist | 0.089 0.021 DBMET01455 | ||
| 0.093 | 0.005 | 0.093 | Ryanodine receptor antagonist | 0.081 0.008 DBMET01455 | ||
| 0.112 | 0.023 | 0.112 | Glycine receptor antagonist | 0.104 0.029 DBMET01455 | ||
| 0.108 | 0.021 | 0.108 | Calcium channel L-type blocker | 0.097 0.026 DBMET01455 | ||
| 0.115 | 0.028 | 0.115 | Cathepsin G inhibitor | 0.104 0.032 DBMET01455 | ||
| 0.117 | 0.032 | 0.117 | Histamine N-methyltransferase inhibitor | 0.087 0.058 DBMET01455 | ||
| 0.101 | 0.016 | 0.101 | Neuraminidase (influenza) inhibitor | 0.086 0.022 DBMET01455 | ||
| 0.096 | 0.011 | 0.096 | Plasminogen activator inhibitor antagonist | 0.06 0.024 DBMET01455 | ||
| 0.103 | 0.02 | 0.103 | Leukotriene antagonist | 0.083 0.03 DBMET01455 | ||
| 0.112 | 0.029 | 0.112 | Transcription factor NF kappa B stimulant | 0.108 0.032 DBMET01455 | ||
| 0.092 | 0.01 | 0.092 | Topoisomerase II beta inhibitor | 0.069 0.017 DBMET01455 | ||
| 0.095 | 0.013 | 0.095 | Heat shock protein 90 beta antagonist | 0.093 0.014 DBMET01455 | ||
| 0.109 | 0.027 | 0.109 | Myeloperoxidase inhibitor | 0.089 0.051 DBMET01455 | ||
| 0.094 | 0.013 | 0.101 | Dihydroorotate dehydrogenase inhibitor | 0.101 0.011 DBMET01455 | DBMET01455 | |
| 0.1 | 0.018 | 0.104 | Biliverdin reductase inhibitor | 0.104 0.017 DBMET01455 | DBMET01455 | |
| 0.12 | 0.039 | 0.12 | Prolactin inhibitor | 0.091 0.066 DBMET01455 | ||
| 0.093 | 0.012 | 0.093 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.09 0.013 DBMET01455 | ||
| 0.097 | 0.016 | 0.097 | MAP kinase kinase 7 inhibitor | 0.084 0.036 DBMET01455 | ||
| 0.088 | 0.007 | 0.088 | Squalene epoxidase inhibitor | 0.083 0.009 DBMET01455 | ||
| 0.135 | 0.054 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.05 DBMET01455 | DBMET01455 | |
| 0.128 | 0.048 | 0.128 | Falcipain 3 inhibitor | 0.087 0.084 DBMET01455 | ||
| 0.128 | 0.048 | 0.128 | Aminopeptidase B inhibitor | 0.101 0.064 DBMET01455 | ||
| 0.115 | 0.036 | 0.115 | Glutamate (mGluR7) agonist | 0.1 0.06 DBMET01455 | ||
| 0.113 | 0.036 | 0.122 | Interleukin 12 antagonist | 0.122 0.027 DBMET01455 | DBMET01455 | |
| 0.103 | 0.026 | 0.103 | Interferon agonist | 0.091 0.038 DBMET01455 | ||
| 0.103 | 0.025 | 0.103 | Estrogen receptor alpha antagonist | 0.1 0.027 DBMET01455 | ||
| 0.142 | 0.066 | 0.142 | Calcium channel blocker | 0.127 0.08 DBMET01455 | ||
| 0.082 | 0.006 | 0.092 | Pregnane X receptor antagonist | 0.092 0.004 DBMET01455 | DBMET01455 | |
| 0.091 | 0.016 | 0.091 | NMDA 2A receptor antagonist | 0.065 0.026 DBMET01455 | ||
| 0.146 | 0.073 | 0.149 | Cyclooxygenase inhibitor | 0.149 0.071 DBMET01455 | DBMET01455 | |
| 0.082 | 0.01 | 0.083 | Dihydroorotate oxidase inhibitor | 0.083 0.009 DBMET01455 | DBMET01455 | |
| 0.076 | 0.004 | 0.079 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.079 0.004 DBMET01455 | DBMET01455 | |
| 0.106 | 0.036 | 0.106 | Topoisomerase II alpha inhibitor | 0.075 0.057 DBMET01455 | ||
| 0.08 | 0.011 | 0.08 | DNA helicase inhibitor | 0.077 0.012 DBMET01455 | ||
| 0.075 | 0.007 | 0.075 | Dihydropteroate synthase inhibitor | 0.061 0.011 DBMET01455 | ||
| 0.082 | 0.015 | 0.082 | Leukotriene B4 antagonist | 0.065 0.023 DBMET01455 | ||
| 0.083 | 0.016 | 0.083 | Beta 1 adrenoreceptor antagonist | 0.074 0.022 DBMET01455 | ||
| 0.095 | 0.029 | 0.095 | Carbonic anhydrase V inhibitor | 0.088 0.031 DBMET01455 | ||
| 0.085 | 0.02 | 0.085 | Interferon inducer | 0.076 0.027 DBMET01455 | ||
| 0.07 | 0.005 | 0.07 | Glutamate (mGluR8) agonist | 0.059 0.007 DBMET01455 | ||
| 0.07 | 0.005 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 DBMET01455 | DBMET01455 | |
| 0.088 | 0.023 | 0.088 | NMDA receptor glycine site agonist | 0.074 0.033 DBMET01455 | ||
| 0.142 | 0.077 | 0.142 | Thiol protease inhibitor | 0.12 0.117 DBMET01455 | ||
| 0.145 | 0.08 | 0.145 | Acetylcholine M1 receptor antagonist | |||
| 0.107 | 0.043 | 0.107 | Protein kinase C zeta inhibitor | |||
| 0.069 | 0.005 | 0.069 | NMDA 2D receptor antagonist | 0.05 0.007 DBMET01455 | ||
| 0.078 | 0.014 | 0.089 | Nicotinic alpha3beta2 receptor antagonist | 0.089 0.01 DBMET01455 | DBMET01455 | |
| 0.122 | 0.059 | 0.122 | Interleukin 8 antagonist | 0.114 0.069 DBMET01455 | ||
| 0.076 | 0.013 | 0.076 | Alpha-mannosidase inhibitor | 0.06 0.027 DBMET01455 | ||
| 0.111 | 0.049 | 0.111 | Sphingomyelinase inhibitor | |||
| 0.069 | 0.007 | 0.069 | DNA gyrase subunit A inhibitor | 0.064 0.009 DBMET01455 | ||
| 0.078 | 0.016 | 0.082 | Heme oxygenase stimulant | 0.082 0.014 DBMET01455 | DBMET01455 | |
| 0.1 | 0.039 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.117 0.022 DBMET01455 | DBMET01455 | |
| 0.07 | 0.009 | 0.07 | Glutamate (mGluR group III) antagonist | 0.056 0.015 DBMET01455 | ||
| 0.095 | 0.036 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 DBMET01455 | DBMET01455 | |
| 0.082 | 0.022 | 0.082 | Estrogen agonist | 0.065 0.028 DBMET01455 | ||
| 0.081 | 0.022 | 0.081 | Carbonic anhydrase VB inhibitor | 0.076 0.024 DBMET01455 | ||
| 0.103 | 0.045 | 0.104 | Thioredoxin inhibitor | 0.104 0.044 DBMET01455 | DBMET01455 | |
| 0.068 | 0.009 | 0.068 | Nicotinic acid receptor agonist | 0.046 0.016 DBMET01455 | ||
| 0.067 | 0.009 | 0.067 | Dopamine D5 agonist | 0.045 0.022 DBMET01455 | ||
| 0.071 | 0.013 | 0.071 | Adenosine deaminase inhibitor | 0.065 0.017 DBMET01455 | ||
| 0.102 | 0.045 | 0.113 | Androgen antagonist | 0.113 0.037 DBMET01455 | DBMET01455 | |
| 0.175 | 0.119 | 0.175 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.077 | 0.021 | 0.08 | Alpha tubulin antagonist | 0.08 0.02 DBMET01455 | DBMET01455 | |
| 0.116 | 0.06 | 0.116 | GABA receptor agonist | 0.106 0.07 DBMET01455 | ||
| 0.172 | 0.117 | 0.172 | Hypolipemic | 0.167 0.121 DBMET01455 | ||
| 0.07 | 0.016 | 0.07 | Estradiol 17 beta-dehydrogenase inhibitor | 0.067 0.017 DBMET01455 | ||
| 0.102 | 0.048 | 0.102 | Phosphodiesterase 6D inhibitor | 0.099 0.054 DBMET01455 | ||
| 0.124 | 0.07 | 0.124 | Cathepsin H inhibitor | 0.114 0.083 DBMET01455 | ||
| 0.063 | 0.01 | 0.063 | Fumarate hydratase inhibitor | 0.045 0.015 DBMET01455 | ||
| 0.065 | 0.012 | 0.065 | AICAR transformylase inhibitor | 0.056 0.017 DBMET01455 | ||
| 0.067 | 0.014 | 0.067 | Heparanase inhibitor | 0.059 0.025 DBMET01455 | ||
| 0.066 | 0.014 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.057 0.021 DBMET01455 | ||
| 0.108 | 0.056 | 0.119 | Gastric antisecretory | 0.119 0.043 DBMET01455 | DBMET01455 | |
| 0.076 | 0.025 | 0.076 | Protein kinase C eta inhibitor | 0.059 0.035 DBMET01455 | ||
| 0.082 | 0.031 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | 0.088 0.025 DBMET01455 | DBMET01455 | |
| 0.071 | 0.02 | 0.071 | Dopamine transporter inhibitor | 0.054 0.028 DBMET01455 | ||
| 0.079 | 0.029 | 0.079 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.046 DBMET01455 | ||
| 0.077 | 0.027 | 0.077 | Argininosuccinate synthase inhibitor | 0.059 0.037 DBMET01455 | ||
| 0.08 | 0.03 | 0.08 | Protein kinase C beta inhibitor | 0.071 0.045 DBMET01455 | ||
| 0.076 | 0.026 | 0.076 | Nitric oxide donor | 0.07 0.033 DBMET01455 | ||
| 0.058 | 0.009 | 0.058 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.048 0.012 DBMET01455 | ||
| 0.064 | 0.015 | 0.064 | Mannosidase inhibitor | 0.044 0.033 DBMET01455 | ||
| 0.085 | 0.038 | 0.085 | Aminopeptidase I inhibitor | 0.075 0.047 DBMET01455 | ||
| 0.072 | 0.025 | 0.072 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 DBMET01455 | ||
| 0.062 | 0.015 | 0.07 | Dihydroorotase inhibitor | 0.07 0.011 DBMET01455 | DBMET01455 | |
| 0.066 | 0.019 | 0.066 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 DBMET01455 | ||
| 0.063 | 0.017 | 0.071 | Leukocyte elastase inhibitor | 0.071 0.014 DBMET01455 | DBMET01455 | |
| 0.088 | 0.042 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | 0.084 0.046 DBMET01455 | ||
| 0.057 | 0.012 | 0.057 | Nerve growth factor antagonist | 0.05 0.018 DBMET01455 | ||
| 0.05 | 0.005 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 DBMET01455 | DBMET01455 | |
| 0.073 | 0.028 | 0.073 | Carbonic anhydrase XII inhibitor | 0.057 0.034 DBMET01455 | ||
| 0.095 | 0.05 | 0.095 | NMDA receptor antagonist | |||
| 0.072 | 0.028 | 0.085 | Transcription factor AP-1 inhibitor | 0.085 0.018 DBMET01455 | DBMET01455 | |
| 0.128 | 0.084 | 0.128 | Nav1.6 sodium channel blocker | 0.124 0.09 DBMET01455 | ||
| 0.067 | 0.025 | 0.067 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET01455 | ||
| 0.072 | 0.029 | 0.072 | Dopamine uptake inhibitor | 0.057 0.041 DBMET01455 | ||
| 0.111 | 0.069 | 0.111 | Interleukin 1b antagonist | 0.097 0.084 DBMET01455 | ||
| 0.053 | 0.011 | 0.053 | Glutamate (mGluR3) antagonist | 0.043 0.018 DBMET01455 | ||
| 0.07 | 0.028 | 0.076 | Calcium channel P-type blocker | 0.076 0.019 DBMET01455 | DBMET01455 | |
| 0.089 | 0.048 | 0.089 | mTOR complex 2 inhibitor | 0.079 0.073 DBMET01455 | ||
| 0.071 | 0.03 | 0.071 | Androgen agonist | 0.069 0.031 DBMET01455 | ||
| 0.079 | 0.038 | 0.079 | Carbonic anhydrase VA inhibitor | 0.075 0.041 DBMET01455 | ||
| 0.062 | 0.021 | 0.062 | Lysophosphatidic acid 3 receptor antagonist | 0.056 0.028 DBMET01455 | ||
| 0.074 | 0.033 | 0.074 | CDC25B inhibitor | 0.067 0.042 DBMET01455 | ||
| 0.053 | 0.013 | 0.053 | Beta adrenoreceptor agonist | 0.046 0.027 DBMET01455 | ||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | 0.058 0.034 DBMET01455 | ||
| 0.123 | 0.083 | 0.123 | Bone formation stimulant | 0.106 0.1 DBMET01455 | ||
| 0.134 | 0.095 | 0.134 | Thrombolytic | |||
| 0.047 | 0.009 | 0.047 | Liver X receptor beta antagonist | 0.041 0.012 DBMET01455 | ||
| 0.062 | 0.024 | 0.062 | Phosphorylase inhibitor | 0.062 0.024 DBMET01455 | ||
| 0.072 | 0.034 | 0.072 | NMDA receptor agonist | 0.061 0.046 DBMET01455 | ||
| 0.044 | 0.006 | 0.044 | Elastase 2B inhibitor | 0.038 0.01 DBMET01455 | ||
| 0.044 | 0.006 | 0.044 | Elastase 3B inhibitor | 0.038 0.01 DBMET01455 | ||
| 0.044 | 0.006 | 0.044 | Elastase 3A inhibitor | 0.038 0.01 DBMET01455 | ||
| 0.051 | 0.013 | 0.051 | Kainate receptor agonist | 0.042 0.028 DBMET01455 | ||
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR4) antagonist | 0.04 0.039 DBMET01455 | ||
| 0.069 | 0.032 | 0.076 | Transcription factor RelA inhibitor | 0.076 0.021 DBMET01455 | DBMET01455 | |
| 0.065 | 0.03 | 0.065 | Fatty acid synthase inhibitor | 0.063 0.032 DBMET01455 | ||
| 0.06 | 0.024 | 0.06 | Immunoglobulin Fc receptor antagonist | |||
| 0.06 | 0.024 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET01455 | ||
| 0.249 | 0.214 | 0.249 | Cyclophilin D inhibitor | |||
| 0.068 | 0.033 | 0.068 | Phosphodiesterase 1C inhibitor | 0.058 0.053 DBMET01455 | ||
| 0.071 | 0.036 | 0.071 | MDM2 inhibitor | 0.069 0.042 DBMET01455 | ||
| 0.048 | 0.014 | 0.048 | Estrogen-related receptor alpha antagonist | 0.047 0.014 DBMET01455 | ||
| 0.087 | 0.053 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.049 | 0.015 | 0.049 | Retinoic acid alpha receptor agonist | 0.048 0.016 DBMET01455 | ||
| 0.052 | 0.018 | 0.052 | Liver X receptor alpha agonist | 0.047 0.022 DBMET01455 | ||
| 0.134 | 0.102 | 0.134 | Growth hormone agonist | |||
| 0.078 | 0.045 | 0.078 | Phosphodiesterase VI inhibitor | 0.075 0.051 DBMET01455 | ||
| 0.049 | 0.017 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.045 0.021 DBMET01455 | ||
| 0.064 | 0.032 | 0.064 | Botulinum neurotoxin type A inhibitor | 0.064 0.032 DBMET01455 | ||
| 0.06 | 0.028 | 0.06 | Thromboxane A2 antagonist | 0.052 0.034 DBMET01455 | ||
| 0.047 | 0.015 | 0.047 | Phosphoglycerate kinase inhibitor | 0.04 0.02 DBMET01455 | ||
| 0.048 | 0.016 | 0.048 | Farnesoid X receptor agonist | 0.043 0.02 DBMET01455 | ||
| 0.039 | 0.008 | 0.039 | Calcium-sensing receptor agonist | 0.038 0.008 DBMET01455 | ||
| 0.109 | 0.079 | 0.114 | Beta amyloid protein antagonist | 0.114 0.073 DBMET01455 | DBMET01455 | |
| 0.054 | 0.024 | 0.054 | Dopamine beta hydroxylase inhibitor | |||
| 0.044 | 0.015 | 0.044 | CF transmembrane conductance regulator antagonist | 0.04 0.025 DBMET01455 | ||
| 0.069 | 0.04 | 0.069 | Carbonic anhydrase inhibitor | 0.058 0.047 DBMET01455 | ||
| 0.107 | 0.078 | 0.109 | Proteasome inhibitor | 0.109 0.075 DBMET01455 | DBMET01455 | |
| 0.059 | 0.03 | 0.059 | Thromboxane synthase inhibitor | 0.053 0.041 DBMET01455 | ||
| 0.039 | 0.01 | 0.039 | Kynurenine 3 monooxygenase inhibitor | 0.036 0.012 DBMET01455 | ||
| 0.041 | 0.012 | 0.05 | ATP citrate lysase inhibitor | 0.05 0.008 DBMET01455 | DBMET01455 | |
| 0.061 | 0.033 | 0.061 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.051 0.047 DBMET01455 | ||
| 0.06 | 0.032 | 0.06 | Thromboxane antagonist | 0.052 0.04 DBMET01455 | ||
| 0.074 | 0.048 | 0.074 | NMDA 2 receptor antagonist | |||
| 0.208 | 0.181 | 0.211 | Calpain 2 inhibitor | 0.211 0.178 DBMET01455 | DBMET01455 | |
| 0.109 | 0.083 | 0.109 | Transcription factor STAT6 inhibitor | |||
| 0.043 | 0.018 | 0.055 | Retinoid X alpha receptor agonist | 0.055 0.013 DBMET01455 | DBMET01455 | |
| 0.052 | 0.027 | 0.052 | Cholesterol esterase inhibitor | 0.044 0.04 DBMET01455 | ||
| 0.034 | 0.009 | 0.034 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DBMET01455 | ||
| 0.066 | 0.041 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.063 | 0.038 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.071 0.027 DBMET01455 | DBMET01455 | |
| 0.094 | 0.069 | 0.094 | Protein kinase (CK2) inhibitor | |||
| 0.041 | 0.017 | 0.041 | Sirtuin 2 inhibitor | 0.03 0.025 DBMET01455 | ||
| 0.045 | 0.02 | 0.045 | GABA uptake inhibitor | |||
| 0.044 | 0.02 | 0.056 | Retinoid X receptor agonist | 0.056 0.015 DBMET01455 | DBMET01455 | |
| 0.051 | 0.027 | 0.051 | Cytokine production stimulant | |||
| 0.047 | 0.023 | 0.047 | GABA B receptor antagonist | |||
| 0.128 | 0.105 | 0.128 | Pregnane X receptor agonist | 0.124 0.117 DBMET01455 | ||
| 0.097 | 0.073 | 0.097 | Topoisomerase I inhibitor | |||
| 0.043 | 0.019 | 0.046 | Retinoid X receptor antagonist | 0.046 0.016 DBMET01455 | DBMET01455 | |
| 0.046 | 0.023 | 0.046 | Angiotensin AT1 receptor antagonist | 0.041 0.03 DBMET01455 | ||
| 0.089 | 0.067 | 0.095 | ABCA1 expression enhancer | 0.095 0.058 DBMET01455 | DBMET01455 | |
| 0.026 | 0.005 | 0.026 | Antibiotic Anthracycline-like | 0.023 0.007 DBMET01455 | ||
| 0.061 | 0.04 | 0.061 | Cyclin D1 inhibitor | |||
| 0.101 | 0.08 | 0.118 | Electron transport complex I inhibitor | 0.118 0.05 DBMET01455 | DBMET01455 | |
| 0.105 | 0.084 | 0.105 | Acetylcholine muscarinic antagonist | |||
| 0.049 | 0.028 | 0.056 | Adenylate cyclase 1 inhibitor | 0.056 0.02 DBMET01455 | DBMET01455 | |
| 0.03 | 0.01 | 0.033 | Retinoic acid receptor agonist | 0.033 0.009 DBMET01455 | DBMET01455 | |
| 0.091 | 0.07 | 0.091 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.028 | 0.008 | 0.028 | Retinoic acid gamma receptor agonist | 0.027 0.008 DBMET01455 | ||
| 0.067 | 0.047 | 0.069 | Potassium channel (ATP-sensitive) blocker | 0.069 0.043 DBMET01455 | DBMET01455 | |
| 0.04 | 0.021 | 0.04 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.024 DBMET01455 | ||
| 0.072 | 0.054 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.027 | 0.008 | 0.028 | Retinoic acid alpha receptor antagonist | 0.028 0.007 DBMET01455 | DBMET01455 | |
| 0.028 | 0.01 | 0.028 | Prostaglandin F2 alpha agonist | 0.021 0.018 DBMET01455 | ||
| 0.052 | 0.034 | 0.052 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.033 | 0.016 | 0.033 | Uridine phosphorylase inhibitor | 0.032 0.016 DBMET01455 | ||
| 0.05 | 0.034 | 0.05 | Factor III inhibitor | |||
| 0.056 | 0.039 | 0.056 | Carbonic anhydrase IX inhibitor | 0.047 0.045 DBMET01455 | ||
| 0.041 | 0.025 | 0.041 | NMDA receptor subunit 3A antagonist | |||
| 0.143 | 0.127 | 0.143 | MAP kinase kinase 2 inhibitor | |||
| 0.039 | 0.023 | 0.039 | Vanilloid 3 antagonist | |||
| 0.023 | 0.007 | 0.023 | Estrogen-related receptor gamma agonist | 0.023 0.007 DBMET01455 | ||
| 0.045 | 0.029 | 0.045 | NMDA receptor subunit 3B antagonist | |||
| 0.057 | 0.042 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.037 | 0.022 | 0.037 | Estrogen receptor beta agonist | 0.029 0.024 DBMET01455 | ||
| 0.036 | 0.021 | 0.037 | Retinoid X alpha receptor antagonist | 0.037 0.018 DBMET01455 | DBMET01455 | |
| 0.035 | 0.02 | 0.035 | Protein kinase (CK2) beta inhibitor | |||
| 0.038 | 0.023 | 0.038 | Nicotinic acid receptor 2 agonist | |||
| 0.167 | 0.153 | 0.167 | Calpain inhibitor | |||
| 0.036 | 0.022 | 0.036 | RNA-directed RNA polymerase inhibitor | |||
| 0.036 | 0.023 | 0.036 | Estrogen receptor alpha agonist | 0.032 0.025 DBMET01455 | ||
| 0.034 | 0.021 | 0.034 | Protein kinase C beta I inhibitor | 0.032 0.029 DBMET01455 | ||
| 0.057 | 0.044 | 0.057 | Acetylcholine M3 receptor antagonist | |||
| 0.031 | 0.018 | 0.031 | Leukotriene B4 receptor 1 antagonist | |||
| 0.079 | 0.066 | 0.079 | Bcr-Abl kinase inhibitor | 0.078 0.066 DBMET01455 | ||
| 0.028 | 0.015 | 0.028 | Nicotinic acid receptor 2 antagonist | 0.024 0.023 DBMET01455 | ||
| 0.159 | 0.146 | 0.159 | Tumour necrosis factor alpha release inhibitor | |||
| 0.146 | 0.133 | 0.146 | Platelet aggregation inhibitor | |||
| 0.065 | 0.053 | 0.07 | Peroxisome proliferator-activated receptor gamma agonist | 0.07 0.049 DBMET01455 | DBMET01455 | |
| 0.034 | 0.022 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.035 | 0.023 | 0.035 | Angiotensin II receptor antagonist | |||
| 0.027 | 0.016 | 0.03 | Thyroid hormone agonist | 0.03 0.012 DBMET01455 | DBMET01455 | |
| 0.024 | 0.013 | 0.024 | Leukotriene B4 receptor 2 antagonist | |||
| 0.046 | 0.035 | 0.057 | Peroxisome proliferator-activated receptor alpha agonist | 0.057 0.027 DBMET01455 | DBMET01455 | |
| 0.026 | 0.015 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 DBMET01455 | DBMET01455 | |
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.022 | 0.011 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.073 | 0.062 | 0.079 | Antineoplastic antibiotic | 0.079 0.058 DBMET01455 | DBMET01455 | |
| 0.057 | 0.046 | 0.057 | Phosphodiesterase 1B inhibitor | |||
| 0.038 | 0.028 | 0.038 | Leukotriene C4 antagonist | |||
| 0.062 | 0.052 | 0.062 | Acetylcholine M5 receptor agonist | |||
| 0.021 | 0.011 | 0.022 | Retinoic acid receptor antagonist | 0.022 0.009 DBMET01455 | DBMET01455 | |
| 0.056 | 0.046 | 0.056 | Lipocortins synthesis agonist | |||
| 0.062 | 0.052 | 0.062 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.057 | 0.047 | 0.057 | Acetylcholine M5 receptor antagonist | |||
| 0.025 | 0.017 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.051 | 0.042 | 0.051 | Carbonic anhydrase I inhibitor | |||
| 0.082 | 0.073 | 0.082 | Phosphodiesterase I inhibitor | |||
| 0.026 | 0.018 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.018 DBMET01455 | DBMET01455 | |
| 0.051 | 0.043 | 0.051 | Carbonic anhydrase II inhibitor | |||
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.03 | 0.023 | 0.03 | HCV NS5B polymerase inhibitor | |||
| 0.032 | 0.025 | 0.032 | Liver X receptor beta agonist | |||
| 0.075 | 0.067 | 0.075 | Phosphodiesterase IV inhibitor | |||
| 0.023 | 0.015 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | |||
| 0.032 | 0.025 | 0.036 | Catechol O-methyltransferase inhibitor | 0.036 0.018 DBMET01455 | DBMET01455 | |
| 0.041 | 0.035 | 0.041 | Purinergic P2Y antagonist | |||
| 0.044 | 0.038 | 0.051 | Aldosterone antagonist | 0.051 0.028 DBMET01455 | DBMET01455 | |
| 0.024 | 0.019 | 0.025 | Methionyl aminopeptidase 2 inhibitor | 0.025 0.018 DBMET01455 | DBMET01455 | |
| 0.12 | 0.114 | 0.12 | MAP3K9 inhibitor | |||
| 0.066 | 0.06 | 0.066 | Histone deacetylase SIRT1 stimulant | |||
| 0.066 | 0.06 | 0.066 | Histone deacetylase stimulant | |||
| 0.037 | 0.032 | 0.037 | Kainate receptor antagonist | |||
| 0.042 | 0.036 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 DBMET01455 | DBMET01455 | |
| 0.029 | 0.024 | 0.029 | Prostaglandin agonist | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | |||
| 0.032 | 0.027 | 0.035 | Free fatty acid receptor 1 antagonist | 0.035 0.022 DBMET01455 | DBMET01455 | |
| 0.021 | 0.016 | 0.021 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.018 DBMET01455 | ||
| 0.03 | 0.025 | 0.036 | Cholesterol ester transfer protein antagonist | 0.036 0.016 DBMET01455 | DBMET01455 | |
| 0.022 | 0.017 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.051 | 0.046 | 0.051 | Epithelial sodium channel blocker | |||
| 0.085 | 0.08 | 0.085 | Bronchodilator | |||
| 0.04 | 0.036 | 0.041 | Geranyltranstransferase inhibitor | 0.041 0.035 DBMET01455 | DBMET01455 | |
| 0.012 | 0.008 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.007 DBMET01455 | ||
| 0.104 | 0.1 | 0.11 | Cyclooxygenase 2 inhibitor | 0.11 0.091 DBMET01455 | DBMET01455 | |
| 0.03 | 0.026 | 0.03 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.012 | 0.008 | 0.012 | Retinoic acid beta receptor antagonist | 0.012 0.008 DBMET01455 | ||
| 0.067 | 0.063 | 0.069 | CDC25A inhibitor | 0.069 0.058 DBMET01455 | DBMET01455 | |
| 0.036 | 0.033 | 0.036 | Toll-Like receptor 2 agonist | |||
| 0.046 | 0.043 | 0.046 | Aldose reductase inhibitor | |||
| 0.193 | 0.19 | 0.25 | Beta lactamase inhibitor | 0.25 0.157 DBMET01455 | DBMET01455 | |
| 0.016 | 0.013 | 0.016 | Ileal bile acid transport inhibitor | |||
| 0.024 | 0.022 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET01455 | ||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.075 | 0.073 | 0.075 | GABA A receptor agonist | |||
| 0.054 | 0.052 | 0.057 | TRPA1 antagonist | 0.057 0.047 DBMET01455 | DBMET01455 | |
| 0.027 | 0.025 | 0.027 | Liver X receptor alpha antagonist | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.033 | 0.032 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.032 DBMET01455 | ||
| 0.043 | 0.042 | 0.048 | Mineralocorticoid receptor antagonist | 0.048 0.033 DBMET01455 | DBMET01455 | |
| 0.06 | 0.059 | 0.102 | HIV-1 reverse transcriptase inhibitor | 0.102 0.03 DBMET01455 | DBMET01455 | |
| 0.015 | 0.014 | 0.015 | Thyroid hormone alpha agonist | |||
| 0.03 | 0.03 | 0.031 | Purinergic P2Y2 antagonist | 0.031 0.028 DBMET01455 | DBMET01455 | |
| 0.019 | 0.019 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.013 DBMET01455 | DBMET01455 | |
| 0.116 | 0.117 | 0.134 | Insulin secretagoues | 0.134 0.092 DBMET01455 | DBMET01455 | |
| 0.047 | 0.049 | 0.052 | Vanilloid 2 antagonist | 0.052 0.037 DBMET01455 | DBMET01455 | |
| 0.125 | 0.128 | 0.134 | LIM domain kinase 1 inhibitor | 0.134 0.116 DBMET01455 | DBMET01455 | |
| 0.015 | 0.018 | 0.02 | Peroxisome proliferator-activated receptor alpha antagonist | 0.02 0.015 DBMET01455 | DBMET01455 | |
| 0.078 | 0.081 | 0.09 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 DBMET01455 | DBMET01455 | |
| 0.026 | 0.029 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DBMET01455 | DBMET01455 | |
| 0.073 | 0.076 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.089 0.048 DBMET01455 | DBMET01455 | |
| 0.059 | 0.065 | 0.067 | Prostaglandin-E synthase inhibitor | 0.067 0.052 DBMET01455 | DBMET01455 | |
| 0.021 | 0.027 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET01455 | DBMET01455 | |
| 0.036 | 0.043 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.036 DBMET01455 | DBMET01455 | |
| 0.006 | 0.014 | 0.01 | Progesterone receptor A antagonist | 0.01 0.006 DBMET01455 | DBMET01455 | |
| 0.017 | 0.026 | 0.023 | Glutamate (mGluR1a) agonist | 0.023 0.014 DBMET01455 | DBMET01455 | |
| 0.032 | 0.042 | 0.039 | Glutamate (mGluR1a) antagonist | 0.039 0.03 DBMET01455 | DBMET01455 | |
| 0.037 | 0.049 | 0.04 | Dihydrofolate reductase inhibitor | 0.04 0.039 DBMET01455 | DBMET01455 | |
| 0.046 | 0.064 | 0.1 | Purinergic P2X2 antagonist | 0.1 0.03 DBMET01455 | DBMET01455 | |
| 0.074 | 0.093 | 0.085 | Vanilloid agonist | 0.085 0.057 DBMET01455 | DBMET01455 | |
| 0.027 | 0.051 | 0.032 | Tubulin agonist | 0.032 0.029 DBMET01455 | DBMET01455 | |
| 0.057 | 0.082 | 0.071 | CYP2A6 inhibitor | 0.071 0.057 DBMET01455 | DBMET01455 | |
| 0.118 | 0.165 | 0.137 | Antimitotic | 0.137 0.136 DBMET01455 | DBMET01455 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |